Diabetes Care Devices - Bosnia and Herzegovina

  • Bosnia and Herzegovina
  • Revenue in the Diabetes Care Devices market market in Bosnia and Herzegovina is anticipated to reach US$7.64m in 2024.
  • The revenue is forecasted to demonstrate an annual growth rate (CAGR 2024-2029) of 12.19%, leading to a market volume of US$13.58m by 2029.
  • In a global context, the majority of revenue is projected to be generated the United States, amounting to US$11,710.00m in 2024.
  • In Bosnia and Herzegovina, the Diabetes Care Devices market is witnessing a growing emphasis on innovative technology solutions to enhance patient management and adherence.

Key regions: Netherlands, Japan, France, Italy, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diabetes Care Devices Market in Bosnia and Herzegovina is witnessing considerable growth, fueled by rising diabetes prevalence, increased healthcare investments, and greater awareness of diabetes management among patients and healthcare providers.

Customer preferences:
Consumers in Bosnia and Herzegovina are increasingly prioritizing personalized diabetes management solutions, which has driven a rise in demand for smart insulin delivery systems and continuous glucose monitoring devices. This shift is influenced by the growing awareness of diabetes education and the importance of lifestyle adjustments among younger populations. Additionally, the integration of mobile health applications is enhancing user engagement, enabling patients to track their health metrics effectively and communicate with healthcare providers seamlessly.

Trends in the market:
In Bosnia and Herzegovina, the Diabetes Care Devices market is experiencing a notable shift towards smart technology, particularly in insulin delivery systems and continuous glucose monitoring devices. This trend is propelled by an increasing focus on personalized diabetes management among consumers, especially the younger demographic, who are becoming more health-conscious. Furthermore, the integration of mobile health applications is fostering improved patient engagement, enabling seamless tracking of health metrics and communication with healthcare providers. This evolution presents significant opportunities for industry stakeholders, including device manufacturers and healthcare providers, to enhance patient outcomes and expand their market reach.

Local special circumstances:
In Bosnia and Herzegovina, the Diabetes Care Devices market is shaped by a unique blend of cultural attitudes towards health and limited access to healthcare resources. The emphasis on family-oriented care often leads to collective decision-making about diabetes management, influencing the adoption of advanced devices. Additionally, the country's diverse geography presents logistical challenges in delivering medical supplies, making efficient distribution critical. Regulatory factors also play a role, as the market is influenced by harmonization efforts with EU standards, impacting the availability and pricing of innovative diabetes care technologies.

Underlying macroeconomic factors:
The Diabetes Care Devices market in Bosnia and Herzegovina is significantly influenced by macroeconomic factors such as national economic stability, healthcare expenditure, and demographic trends. Economic growth, albeit modest, impacts disposable income levels, affecting the affordability of advanced diabetes care devices. Additionally, the government's fiscal policies, including healthcare funding and subsidies for medical technologies, play a crucial role in market accessibility. Global economic trends, such as fluctuations in medical supply costs and currency exchange rates, also affect the pricing and availability of diabetes care devices. Furthermore, the rising prevalence of diabetes in the region amplifies the demand for innovative solutions, driving market expansion.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)